Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating a cancer admission score for emergency department patients

Official title: The Internal Prospective validatiON of a prediCtiOn Model for the Change of admIssion for Patient With caNcer Admitted to the emerGency Department (ONCOMING Study)

Run by Erasmus Medical Center · NCT06558487 · Data updated 2026-11-12

This study is testing a new scoring system to see if it can help doctors better predict what will happen to cancer patients who come to the emergency room, while also trying out a way to speed up their care if they score high.

More Psycho-Oncology trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations1 site (Rotterdam, South Holland)
StatusRecruiting
StartedDecember 2, 2024
Main results expectedDecember 1, 2025
Study endsDecember 31, 2025
Registry record updatedAugust 15, 2025
Trial IDNCT06558487 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with solid or hematological malignancies who are currently receiving or have recently received systemic therapy and are presenting to the emergency department.

Probably not a fit

Patients under 18 years old or those who have only undergone surgical treatment for cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the accuracy of the Cancer Admission Score (CAS) in predicting the disposition of patients with active cancer who visit the emergency department. It involves calculating the CAS after triage and after initial blood results, comparing predicted outcomes with actual patient dispositions. Additionally, an early bed reservation intervention will be tested for patients with a high CAS score to improve care efficiency. The study will also track metrics such as length of stay and time-to-disposition.

Why it matters

Potential benefit: If successful, this study could enhance emergency care for cancer patients by improving the accuracy of admission predictions and optimizing resource allocation.

How similar studies have gone: While the CAS model is being evaluated in this context, similar predictive models in emergency care have shown promise, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
* Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.

Exclusion Criteria:

* \<18 years old
* Only received a surgical intervention as cancer treatment
* Admitted to the ED for the surgical department

Where it's running

  • Erasmus University Medical Center
    Rotterdam, South Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.